Carl-WilhelmErnstVogelMD

PubMed

• 14 citations
  The Role of Complement in Myocardial Infarction Reperfusion Injury: An Underappreciated Therapeutic Target.
  Carl-Wilhelm Vogel> ;Frontiers in Cell and Developmental Biology. 2020 Dec 23
• 1 citations
  Identification of intermolecular bonds between human factor B and Cobra Venom Factor important for C3 convertase stability.
  Brian E. Hew, Michael K. Pangburn, Carl-Wilhelm Vogel, David C. Fritzinger> ;Toxicon. 2020 Sep 1
• 7 citations
  Addressing Cancer Health Disparities in the Pacific Peoples of Hawai‘i, Guam, and the US Associated Pacific Islands Through Pacific-Focused Research Capacity Building
  Rachael T. Leon Guerrero, Neal A Palafox, Margaret Hattori-Uchima, Hali R. Robinett, Carl-Wilhelm Vogel> ;JCO Global Oncology. 2020 Jan 13
• 1 citations
  Identification of functionally important amino acid sequences in cobra venom factor using human C3/Cobra venom factor hybrid proteins
  Brian E. Hew, David C. Fritzinger, Michael K. Pangburn, Carl-Wilhelm Vogel> ;Toxicon. 2019 Sep 1
• 1 citations
  A Unique Partnership Between the University of Hawai'i Cancer Center and the University of Guam: Fifteen Years of Addressing Cancer Health Disparities in Pacific Islan...
  Hali R. Robinett, Rachael T. Leon Guerrero, John A. Peterson, David C. Ward, Neal A Palafox, Carl-Wilhelm Vogel> ;Hawai'i Journal of Medicine & Public Health. 2019 Jun 1
• 8 citations
  Absence of a neutralizing antibody response to humanized cobra venom factor in mice.
  Mathieu Ing, Brian E. Hew, David C. Fritzinger, Sandrine Delignat, Sébastien Lacroix-Desmazes, Carl-Wilhelm Vogel, Julie Rayes> ;Molecular Immunology. 2018 May 1
• 16 citations
  Complement C3 is a novel modulator of the anti-factor VIII immune response
  Julie Rayes, Mathieu Ing, Sandrine Delignat, Ivan Peyron, Laurent Gilardin, Carl-Wilhelm Vogel, David C. Fritzinger, Véronique Frémeaux-Bacchi, Srinivas V. Kaveri, Lub...> ;Haematologica. 2017 Nov 16
• 41 citations
  From basic mechanisms to clinical applications in heart protection, new players in cardiovascular diseases and cardiac theranostics: meeting report from the third inte...
  Hector A. Cabrera-Fuentes, Julián Aragonés, Jürgen Bernhagen, Andreas Boening, William A. Boisvert, Hans Erik Bøtker, Heerajnarain Bulluck, Stuart A. Cook, Fabio Di Li...> ;Basic Research in Cardiology. 2016 Oct 14
• 26 citations
  Meeting report from the 2nd International Symposium on New Frontiers in Cardiovascular Research. Protecting the cardiovascular system from ischemia: between bench and ...
  Hector A. Cabrera-Fuentes, Corina Alba-Alba, Julián Aragonés, Jürgen Bernhagen, William A. Boisvert, Hans Erik Bøtker, Gabriela Cesarman-Maus, Ingrid Fleming, David Ga...> ;Basic Research in Cardiology. 2016 Jan 1
• 20 citations
  Humanized cobra venom factor: Structure, activity, and therapeutic efficacy in preclinical disease models
  Carl-Wilhelm Vogel, Paul W. Finnegan, David C. Fritzinger> ;Molecular Immunology. 2014 Oct 1
• 13 citations
  Complement depletion with humanised cobra venom factor: Efficacy in preclinical models of vascular diseases
  Carl-Wilhelm Vogel, David C. Fritzinger, William B. Gorsuch, Gregory L. Stahl> ;Thrombosis and Haemostasis. 2014 Jul 17
• 2 citations
  University of Hawai'i Cancer Center Connection: regional cooperation in addressing cancer health disparities: NCI's Geographic Management Program (GMaP) and Biospecime...
  Hali R. Robinett, Heidi Harbach, Carl-Wilhelm Vogel> ;Hawai'i Journal of Medicine & Public Health. 2014 Jan 1
• 1 citations
  The 17th World Congress of the International Society on Toxinology and Venom Week 2012.
  Carl-Wilhelm Vogel, Steven A. Seifert> ;Toxicon. 2013 Jul 1
• 7 citations
  Hybrid proteins of Cobra Venom Factor and cobra C3: tools to identify functionally important regions in Cobra Venom Factor.
  Brian E. Hew, Daniel Wehrhahn, David C. Fritzinger, Carl-Wilhelm Vogel> ;Toxicon. 2012 Sep 15
• 3 citations
  UH Cancer Center Hotline: the training and education program of the University of Guam/University of Hawai'i Cancer Center Partnership.
  Hali R. Robinett, Todd Ames, John A. Peterson, Helen J.D. Whippy, Carl-Wilhelm Vogel> ;Hawaii Medical Journal. 2011 Nov 1
• 112 citations
  Cobra venom factor: Structure, function, and humanization for therapeutic complement depletion.
  Carl-Wilhelm Vogel, David C. Fritzinger> ;Toxicon. 2010 Dec 15
• 3 citations
  A partnership between the cancer research center of Hawaii and the University of Guam in Cancer Research, Education, Training, and Outreach.
  Carl-Wilhelm Vogel, Helen J.D. Whippy, Neal R Robinett> ;Hawaii Medical Journal. 2010 Jun 1
• 15 citations
  Complement depletion with humanized cobra venom factor in a mouse model of age-related macular degeneration.
  David C. Fritzinger, Robin Dean, Carol Meschter, Katina Wong, Roman Halter, Jürgen Borlak, William D. St. John, Carl-Wilhelm Vogel> ;Advances in Experimental Medicine and Biology. 2010 Jan 1
• 28 citations
  Humanized cobra venom factor decreases myocardial ischemia reperfusion injury
  W. Brian Gorsuch, Benjamin J. Guikema, David C. Fritzinger, Carl-Wilhelm Vogel, Gregory L. Stahl> ;Molecular Immunology. 2009 Dec 1
• 56 citations
  Insights into complement convertase formation based on the structure of the factor B-cobra venom factor complex
  Bert J. C. Janssen, Lucio Gomes, Roman I. Koning, Dmitri I. Svergun, Abraham J. Koster, David C. Fritzinger, Carl-Wilhelm Vogel, Piet Gros> ;The EMBO Journal. 2009 Aug 19
• 26 citations
  Functional characterization of human C3/cobra venom factor hybrid proteins for therapeutic complement depletion.
  David C. Fritzinger, Brian E. Hew, Mike Thorne, Michael K. Pangburn, Bert J. C. Janssen, Piet Gros, Carl-Wilhelm Vogel> ;Developmental and Comparative Immunology. 2009 Jan 1
• 98 citations
  Depletion of the C3 component of complement enhances the ability of rituximab-coated target cells to activate human NK cells and improves the efficacy of monoclonal an...
  Siao-Yi Wang, Suresh Veeramani, Emilian Racila, Jeffrey R. Cagley, David C. Fritzinger, Carl-Wilhelm Vogel, William D. St. John, George J. Weiner> ;Blood. 2008 Nov 16
• 12 citations
  Derivatives of Human Complement Component C3 for Therapeutic Complement Depletion: A Novel Class of Therapeutic Agents
  David C. Fritzinger, Brian E. Hew, June Q. Lee, James S. Newhouse, Maqsudul Alam, John R. Ciallella, Mallory E. Bowers, William B. Gorsuch, Benjamin J. Guikema, Gregor...> ;Advances in Experimental Medicine and Biology. 2008 Jan 1
• 22 citations
  Humanized cobra venom factor: experimental therapeutics for targeted complement activation and complement depletion.
  Carl-Wilhelm Vogel, David C. Fritzinger> ;Current Pharmaceutical Design. 2007 Sep 30
• 21 citations
  Actin-binding protein filamin A is displayed on the surface of human neuroblastoma cells.
  André S. Bachmann, James P. Howard, Carl-Wilhelm Vogel> ;Cancer Science. 2006 Dec 1
• Join now to see all